
    
      Study drug will be provided as 50 mg tablets. Patients will be instructed to take 2 tablets
      orally once a day during the evening at least 60 minutes after a meal. Thalidomide will be
      administered starting at 100 mg (Group 1) for 6 weeks. Thereafter, the dose will be increased
      every week by 50mg until reaching the dose of 400 mg/day. This treatment is continued for 12
      weeks. Thalidomide is administered in conjunction with the standard treatment of riluzole
      (100mg/day).
    
  